Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Haematologica|August 30, 2012
Genetic modification of human T lymphocytes for the treatment of hematologic malignanciesValentina Hoyos, Barbara Savoldo, Gianpietro Dotti
Blood|May 22, 2016
Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignanciesChuang Sun, Gianpietro Dotti, Barbara Savoldo
The Journal of Clinical Investigation|January 16, 2024
CAR T cells for hematological malignanciesBarbara Savoldo, Natalie Grover, Gianpietro Dotti
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Chimeric Antigen Receptors for Cancer ImmunotherapyClaudia Geldres, Barbara Savoldo, Gianpietro Dotti
Human Gene Therapy|August 26, 2009
Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?"Gianpietro Dotti, Barbara Savoldo, Malcolm Brenner
Seminars in Immunology|January 23, 2016
Chimeric antigen receptor-redirected T cells return to the benchClaudia Geldres, Barbara Savoldo, Gianpietro Dotti
Seminars in Immunology|December 2, 2020
Adoptive T cell therapy: Boosting the immune system to fight cancerErnesto Leon, Raghuveer Ranganathan, Barbara Savoldo
Pediatric Clinics of North America|April 8, 2010
Posttransplant lymphoproliferative diseasesThomas G Gross, Barbara Savoldo, Angela Punnett
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CD19-CAR trialsCarlos A Ramos, Barbara Savoldo, Gianpietro Dotti
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Genetic modification of cytotoxic T lymphocytes to express cytokine receptorsSerena K Perna, Barbara Savoldo, Gianpietro Dotti
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Haematologica|August 30, 2012
Genetic modification of human T lymphocytes for the treatment of hematologic malignanciesValentina Hoyos, Barbara Savoldo, Gianpietro Dotti
Blood|May 22, 2016
Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignanciesChuang Sun, Gianpietro Dotti, Barbara Savoldo
The Journal of Clinical Investigation|January 16, 2024
CAR T cells for hematological malignanciesBarbara Savoldo, Natalie Grover, Gianpietro Dotti
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Chimeric Antigen Receptors for Cancer ImmunotherapyClaudia Geldres, Barbara Savoldo, Gianpietro Dotti
Human Gene Therapy|August 26, 2009
Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?"Gianpietro Dotti, Barbara Savoldo, Malcolm Brenner
Seminars in Immunology|January 23, 2016
Chimeric antigen receptor-redirected T cells return to the benchClaudia Geldres, Barbara Savoldo, Gianpietro Dotti
Seminars in Immunology|December 2, 2020
Adoptive T cell therapy: Boosting the immune system to fight cancerErnesto Leon, Raghuveer Ranganathan, Barbara Savoldo
Pediatric Clinics of North America|April 8, 2010
Posttransplant lymphoproliferative diseasesThomas G Gross, Barbara Savoldo, Angela Punnett
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CD19-CAR trialsCarlos A Ramos, Barbara Savoldo, Gianpietro Dotti
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Genetic modification of cytotoxic T lymphocytes to express cytokine receptorsSerena K Perna, Barbara Savoldo, Gianpietro Dotti
Pageof 16